DINARA ABUBAKIROVA: Open Payments
NPI 1023669140 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 11 payments from 6 companies in 2025. Trend: 2023 $2,982 · 2024 $1,900 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $448 |
| Syndax Pharmaceuticals, Inc. | 1 | $146 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| GENZYME CORPORATION | 1 | $123 |
| Regeneron Healthcare Solutions, Inc. | 1 | $120 |
| PFIZER INC. | 1 | $26 |
Products named: TREMFYA, REVUFORJ, SARCLISA, RYBREVANT, LIBTAYO, ERLEADA, PADCEV.
Industry payments across FL — which companies pay providers there.
